Predict your next investment

Corporation
HEALTHCARE
danaher.com

See what CB Insights has to offer

Investments

3

Portfolio Exits

5

Partners & Customers

6

About Danaher

Danaher (NYSE: DHR) is a science and technology company that designs, manufactures, and markets products and services to professional, medical, industrial, environmental, and commercial customers.

Danaher Headquarter Location

2200 Pennsylvania Avenue, NW Suite 800W

Washington, DC, 20037,

United States

202-828-0850

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Danaher

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Danaher in 1 Expert Collection, including Fortune 500 Investor list.

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

Danaher Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Danaher Rank

Research containing Danaher

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Danaher in 1 CB Insights research brief, most recently on Mar 19, 2020.

Latest Danaher News

UK Professional Cleaning Products Market Research Report 2022 Featuring Clorox Company, Paul Hartmann AG, Reckitt Benckiser Group & Unilever

May 20, 2022

The UK Professional Cleaning (Sanitization & Disinfectant) Products market held a market value of USD 1,414.8 Million in 2021 and is estimated to reach USD 3,832.3 Million by the year 2030. The market is expected to register a growth rate of 11.94% over the projected period. In 2021, approximately 1,769.4 million tonnes of professional cleaning products were sold. The market is expected to be negatively influenced by the existence of counterfeit disinfectants and dermatological disorders due to alcohol-based hand sanitizer (ABHS). The COVID-19 pandemic has tremendously increased the demand for professional cleaning products for sanitization and disinfection purposes. Growth Influencers: High standards of cleanliness, health, and hygiene Sanitization and disinfection play a vital role in various industries, such as hospitality, retail, food & beverage, and healthcare, among others. All these industries have direct interaction with their clients or customers; hence they demand high standards of cleanliness, health, and hygiene. This demand has further increased with the COVID-19 pandemic. Hence, high standards of cleanliness, health, and hygiene are increasing the demand for professional cleaning products, hence fuelling the market growth. Segments Overview: The UK Professional Cleaning (Sanitization & Disinfectant) Products market is segmented into product type, fragrance, packaging, application, end user, distribution channel, and point of usage. By Product Type Others The hand wash/soaps segment accounted for the largest market share of around 15% in 2021 owing to their easy availability and high usage. The hand sanitizers segment is estimated to witness the fastest growth rate of 15.13% over the projected period due to their high demand since the COVID-19 pandemic. Within this segment, the gel sanitizers segment is expected to hold the largest market share of over 60% in 2021 due to the high number of players manufacturing gel sanitizers. Furthermore, the wipes segment is estimated to surpass a market size of USD 50 million by 2026 owing to their growing penetration in the U.K. By Fragrance Others The fresh and clean segment holds the largest market share of over 1/5th of the total market size owing to their growing demand. The herbal segment witnessed the fastest growth rate of over 13% over the forecast period owing to the rising popularity of herbal or chemical free products, including cleaning products. The citrus segment is anticipated to generate a revenue of over USD 800 million by 2030 due to the high number of citrus products in the market. By Packaging Industrial Packaging (< 5L) The commercial retail packaging (>5L) segment is anticipated to witness the fastest growth rate of over 12.15% owing to the growing demand professional cleaning products for commercial purposes. By Application Others The hospitality segment of the highest growth rate of over 13% owing to the increasing awareness regarding maintaining hygiene in the hospitality sector. Within this segment, the hotels sub-segment accounted for the largest market share of around 40% owing to the rapidly growing hotel industry. The enterprises (offices) segment is expected to account for more than 1/5th of the market share by 2030 owing to the improving sanitization and disinfection protocols in enterprises. The educational institutes segment is estimated hold a market opportunity of over USD 30 million during 2022-2030 owing to the rising demand for cleaning products in educational institutes. Within the retail segment, the supermarket/hypermarket sub-segment witnessed the highest CAGR of 11% over the forecast period. By Distribution Channel Wholesale Stores The retail stores segment holds a market share of around 45% in 2021 owing to easy availability of disinfection and sanitization products in retail outlets. The online stores segment is anticipated to witness the highest growth rate of around 13% from 2022-2030 owing to the high adoption of e-commerce platforms, especially during the COVID-19 pandemic. By Point of Usage Back of the House The front of the house segment is expected to account for the largest market share of over 70% by 2030 as front of the house is the more preferred entrance point for clients, guests, and customers, among other people entering any institution or house. Competitive Landscape Major players operating in the UK Professional Cleaning (Sanitization & Disinfectant) Products market include Cleenol, Quat-Chem Ltd., a Neogen Company, Talbot Chemicals Ltd., Sechelle Manufacturing Limited, Zamo Household Products Ltd., Evans Vanodine International Plc, Multex Chemicals Limited, Amity Ltd., Andway Healthcare Ltd., Citron Hygiene, Marken Chemicals, 3M Group, Cantel Medical Corporation, CarrollClean, Clorox Company, Diversey, Inc., Ecolab Inc., GOJO Industries, Inc., Medline Industries, Inc., Metrex Research, LLC (Danaher Corporation), Montgomery Manufacturing, Paul Hartmann AG, Proctor and Gamble, Reckitt Benckiser Group plc, STERIS plc, Unilever, Whiteley Corporation, and Other Prominent Players. The cumulative market share of the four major players is close to 25%. These market players are investing in product launches, collaborations, mergers & acquisitions, and expansions to create a competitive edge in the market. For instance, in July 2021, Hartmann became the hygiene partner of the Allianz Arena in Munich. The start of the 2021/2022 season marked the launch of the partnership between HARTMANN and the Allianz Arena. The arena is set to be equipped with Sterillium disinfection dispensers. For more information about this report visit https://www.researchandmarkets.com/r/li4z29 Attachment

Danaher Investments

3 Investments

Danaher has made 3 investments. Their latest investment was in DNA Script as part of their Series C on October 10, 2021.

CBI Logo

Danaher Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/26/2021

Series C

DNA Script

$165M

No

17

7/29/2020

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

9/20/2004

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/26/2021

7/29/2020

9/20/2004

Round

Series C

Series B - II

Unattributed VC

Company

DNA Script

Subscribe to see more

Subscribe to see more

Amount

$165M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

17

10

0

Danaher Portfolio Exits

5 Portfolio Exits

Danaher has 5 portfolio exits. Their latest portfolio exit was Danaher - ForteBio & SoloHill on October 21, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/21/2019

Divestiture

$99M

5

9/18/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/3/2015

Merger

Subscribe to see more

Subscribe to see more

10

2/4/2013

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

10/22/2007

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/21/2019

9/18/2019

3/3/2015

2/4/2013

10/22/2007

Exit

Divestiture

IPO

Merger

Acq - Fin

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

0

Danaher Acquisitions

18 Acquisitions

Danaher acquired 18 companies. Their latest acquisition was Aldevron on June 17, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/17/2021

Private Equity

$99M

Acquired

16

6/1/2021

Grant

$99M

$36.75M

Acquired

3

7/15/2020

Debt

$99M

$5.75M

Acquired

3

2/25/2019

Subscribe to see more

$99M

Subscribe to see more

10

3/9/2018

Growth Equity

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

6/17/2021

6/1/2021

7/15/2020

2/25/2019

3/9/2018

Investment Stage

Private Equity

Grant

Debt

Growth Equity

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$36.75M

$5.75M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

16

3

3

10

10

Danaher Partners & Customers

6 Partners and customers

Danaher has 6 strategic partners and customers. Danaher recently partnered with Society of Women Engineers on March 3, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

3/21/2018

Partner

United States

2

7/1/2017

Partner

Germany

Subscribe to see more

Subscribe to see more

10

3/8/2016

Partner

India

Subscribe to see more

Subscribe to see more

10

1/12/2016

Partner

United States

Subscribe to see more

Subscribe to see more

10

11/27/2013

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

3/21/2018

7/1/2017

3/8/2016

1/12/2016

11/27/2013

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Country

United States

Germany

India

United States

United States

News Snippet

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Danaher Team

37 Team Members

Danaher has 37 team members, including current Chief Executive Officer, President, H. Lawrence Culp.

Name

Work History

Title

Status

H. Lawrence Culp

Chief Executive Officer, President

Current

Thomas P Joyce

Executive Vice President

Current

David Bangert

President

Former

Jeffrey Beck

President

Former

Scott Clawson

President

Former

Name

H. Lawrence Culp

Thomas P Joyce

David Bangert

Jeffrey Beck

Scott Clawson

Work History

Title

Chief Executive Officer, President

Executive Vice President

President

President

President

Status

Current

Current

Former

Former

Former

You May Also Like

Spotlab Logo
Spotlab

Spotlab develops an ecosystem of portable devices connected and controlled with a smartphone to acquire medical images. It is a platform to diagnose remotely, and an artificial intelligence and crowdsourcing assistant that automates part of the analysis of the images.

OncoHost Logo
OncoHost

OncoHost combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, the company aims to understand patients' unique response to therapy and overcome one of the major obstacles in clinical oncology: resistance to therapy. OncoHost's host response profiling platform, PROphet®, analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient (i.e. the host) in response to a given cancer therapy. This proteomic profile is highly predictive of individual patient outcome, thus enabling personalized treatment planning. PROphet® also identifies potential drug targets, advancing the development of therapeutic strategies, as well as rationally-based combination therapies. The company was founded in 2017 and is based in Binyamina, Israel.

Haemonetics Logo
Haemonetics

Haemonetics is a medical device company. It had developed the Haemonetics Cell Saver Elite Autotransfusion System.Haemonetics is a global company that markets automated blood processing systems. These systems help increase the safety, quality and availability of the world blood supply by addressing important medical markets: surgical blood salvage, blood component collections and plasma collections.

Truvian Sciences Logo
Truvian Sciences

Truvian Sciences is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system produces lab-accurate results for a full suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian's system delivers an alternative to off-site labs, providing immediate insights to inform healthcare decisions.

PixCell Medical Technologies Logo
PixCell Medical Technologies

PixCell Medical Technologies is a privately held company developing cell-based diagnostics for the point of care (POC), based on its viscoelastic focusing and microfluidics technology. The company's core technology is comprised of an analyzer and a self-contained disposable cartridge.On May 3, 2021, PixCell Medical Technologies was acquired by Soulbrain. The terms of the transaction were not disclosed.

BD Logo
BD

BD is a medical technology company that manufactures and sells a broad range of supplies, devices, and systems for use by healthcare professionals, medical research institutions, industry, and the general public.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.